Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's quarterly earnings results, drug pipeline outlook, the ...

The funds will be used to advance Agomab’s candidates through clinical trials, including AGMB-129 for patients with ...

Head of Investor Relations Welcome to the Q3 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide number 3. Here we have the usual ...

Sanofi reported stronger-than-expected third-quarter earnings on Friday, driven by early vaccine sales and robust performance ...

Sanofi to present dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria at ACAAI: Paris Saturday, October 26, 2024, 12:00 Hrs [IST] Positive data from the ...

- Subdued session overall but looking forward to an action-pack week ahead. Session saw cautious tone as market's focus on ...

Treatment MarketThe global castration-resistant prostate cancer (CRPC) treatment market is poised for substantial growth, ...

Global stocks were trading higher on Friday, although they were set for a weekly loss amid US election jitters, while oil ...

HCA Healthcare missed Wall Street estimates for quarterly profit on Friday and forecast up to a $300-million hit in the ...

PARIS: Europe’s main stock index closed Friday’s choppy session flat and notched weekly losses, as a handful of weak ...

The global vaccines market is poised for extraordinary growth, with projections indicating a Compound Annual Growth Rate (CAGR) of 6.6%. This anticipated expansion will elevate the market from its ...

The growth of the severe asthma treatment market can be attributed to the increasing prevalence of asthma worldwide, coupled ...